Simultaneous detection of measles virus, rubella virus, and parvovirus B19 by using multiplex PCR

Journal of Clinical Microbiology

Volumn 40, Issue 1, 2002, Pages 111-116

  Mosquera, M D M ^a   De Ory, F ^a   Moreno, M ^a   Echevarria J E ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASSAY; CEREBROSPINAL FLUID ANALYSIS; CHILD; CONGENITAL RUBELLA SYNDROME; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LABORATORY DIAGNOSIS; MEASLES; MEASLES VIRUS; NONHUMAN; PARVOVIRUS; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RUBELLA VIRUS; THROAT CULTURE; UNINDEXED SEQUENCE; VIRUS DETECTION;

CHILD; DNA, VIRAL; ERYTHEMA INFECTIOSUM; HUMANS; MEASLES; MEASLES VIRUS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; RUBELLA; RUBELLA VIRUS; SENSITIVITY AND SPECIFICITY;

MEASLES VIRUS; PARVOVIRUS; RUBELLA VIRUS;

EID: 0036136513     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.1.111-116.2002     Document Type: Article

References (46)

1. Genetic diversity of wild-type measles viruses: Implications for global measles elimination programs
2. Skin manifestations of internal disease
3. PCR for detection of rubella virus RNA in clinical samples
4. Measles surveillance: Guidelines for laboratory support
5. Rapid and sensitive method for the detection of B19 virus DNA using the polymerase chain reaction with nested primers
6. New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay
7. Detection of enteroviral RNA and specific DNA of herpesviruses by multiplex genome amplification
8. Evidence for persistence of human parvovirus B19 DNA in bone marrow
9. Human parvovirus B19 infections: Routine diagnosis by a new nested polymerase chain reaction assay
10. Advances in global measles control and elimination: Summary of the 1997 international meeting
11. Global measles control and regional elimination, 1998-1999
12. A sensitive and robust method for measles RNA detection
13. Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens
14. Comparative evaluation of commercial methods for the detection of parvovirus B19-specific immunoglobulin M
15. Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA
16. Detection of rubella virus gene sequences by enzymatic amplification and direct sequencing of amplified DNA
17. Detection of human parvovirus B19 DNA PCR products by RNA probe hybridization enzyme immunoassay
18. Neurological aspects of rubella virus infection
19. Polymerase chain reaction with double primer pairs for detection of human parvovirus B19 induced aplastic crises in family outbreaks
20. Measles virus
21. Diagnosis of measles with an IgM capture EIA: The optimal timing of specimen collection after rash onset
22. Estimation of serum concentration of parvovirus B19 DNA by PCR in patients with chronic anaemia
23. Diagnosis of foetal rubella virus infection by polymerase chain reaction
24. Detection of human parvovirus B19 DNA by using the polymerase chain reaction
25. Prenatal diagnosis of human parvovirus B19 in nonimmune hydrops fetalis by polymerase chain reaction
26. Partial amplification of the measles virus nucleocapsid gene from stored sera and cerebrospinal fluids for molecular epidemiological studies
27. Immune response to B19 parvovirus and an antibody defect in persistent viral infection
28. Measles virus infections of the central nervous system
29. Detection of measles virus from clinical samples using the polymerase chain reaction
30. Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability
31. Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19
32. Strategic plan for the elimination of measles in the European Region. Seventh meeting of national programme managers
33. Prenatal diagnosis of rubella virus infection by direct detection and semiquantitation of viral RNA in clinical samples by reverse transcription-PCR
34. Use of reverse-transcription polymerase chain reaction for detection of rubella virus RNA in cell cultures inoculated with clinical samples
35. Investigation of optimal specimen type and sampling time for detection of measles virus RNA during a measles epidemic
36. Collaborative study to assess the suitability of a proposed working reagent for human parvovirus B19 DNA detection in plasma pools by gene amplification techniques
37. Diagnosis of human parvovirus B19 infections by polymerase chain reaction
38. Detection of parvovirus B19 by dot-blot and polymerase chain reaction
39. Polymerase chain reaction for detection of measles virus in clinical samples
40. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy
41. Diagnosis of foetal rubella infection with reverse transcription and nested polymerase chain reaction: A study of 34 cases diagnosed in foetuses
42. Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection
43. Rubella
44. Expanded Programme on Immunisation (EPI). Standardisation of the nomenclature for describing the genetic characteristics of wild-type measles viruses
45. Detection of human parvovirus B19 DNA by nested polymerase chain reaction
46. Parvoviruses